Viking Therapeutics
VKTX
#2790
Rank
C$6.78 B
Marketcap
$60.93
Share price
0.17%
Change (1 day)
140.11%
Change (1 year)

Viking Therapeutics (VKTX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$38.06 Million

According to Viking Therapeutics 's latest financial reports the company's total liabilities are C$38.06 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Viking Therapeutics - Total liabilities on balance sheet (from 2014 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$26.62 M-15.46%
2022-12-31C$31.49 M181.49%
2021-12-31C$11.18 M-27.84%
2020-12-31C$15.5 M66.31%
2019-12-31C$9.32 M50%
2018-12-31C$6.21 M-42.9%
2017-12-31C$10.88 M24.74%
2016-12-31C$8.72 M-6.32%
2015-12-31C$9.31 M-68.12%
2014-12-31C$29.21 M6266.91%
2013-12-31C$0.45 M337.68%
2012-12-31C$0.1 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$1.70 B 4,380.11%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.17 B 2,978.51%๐Ÿ‡บ๐Ÿ‡ธ USA